AngioDynamics to Hold Fiscal 2009 Fourth Quarter and Full Year Financial Results Conference Call on July 16, 2009

July 2, 2009 at 12:00 AM EDT
AngioDynamics to Hold Fiscal 2009 Fourth Quarter and Full Year Financial Results Conference Call on July 16, 2009QUEENSBURY, N.Y.--(BUSINESS WIRE)--Jul. 2, 2009-- AngioDynamics, Inc.(NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal 2009 fourth quarter and full year financial results on Thursday, July 16, 2009, after the close of the financial markets.

Jan Keltjens, President and Chief Executive Officer, and Joseph Gersuk, Executive Vice President and CFO, will host an investment community conference call beginning at 4:30 p.m. Eastern time on July 16 to discuss these results and to answer questions.

To participate in the live call by telephone, please dial +1 (877) 941-8609 from the U.S., or for international callers, please dial +1 (480) 629-9818.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics’ Web site at http://investor.angiodynamics.com. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software.

A replay will be available on the Web site. A telephone replay will be available from 6:30 p.m. Eastern time on July 16, 2009, through 11:59 p.m. Eastern time on July 23 by dialing +1 (800) 406-7325 (domestic) or +1 (303) 590-3030 (international) and entering the passcode: 4104137#.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. The Company’s diverse product line includes market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

Source: AngioDynamics, Inc.

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Doug Sherk, 415-896-6820 (Investor Relations)
dsherk@evcgroup.com
Jenifer Kirtland, 415-896-6820 (Investor Relations)
jkirtland@evcgroup.com
or
EVC Group, Inc.
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com